Drug intelligence / Profile preview

Bao Er Ning

Development stage: Unknown
Lead developer: Henan Purui Pharmaceutical
Administration: Oral

Overview

Bao Er Ning is an approved traditional Chinese patent medicine (TCPM) formulated as an oral syrup, primarily used in pediatric medicine. Developed by Henan Purui Pharmaceutical through its subsidiary Shanghai Xinren Chinese Medicine Pharmaceutical, the product is designed to tonify the spleen, replenish Qi, and strengthen the immune system in children. It is frequently indicated for the treatment and prevention of recurrent respiratory tract infections, loss of appetite (anorexia), and general physical weakness in pediatric patients. The formulation typically consists of a blend of traditional Chinese herbs, including Astragalus, Atractylodes, and Saposhnikovia, which are traditionally used to enhance the body's 'Wei Qi' (defensive energy).

Brand names: Bao'ernin syrupBao Er Ning Tang Jiang
Other names: Bao Er Ning syrup

Beyond the preview

Go deeper on Bao Er Ning.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bao Er Ning.

Explore the full profile